Randomized Feasibility Trial of Mind My Mind (MindMyMind)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03448809 |
|
Recruitment Status :
Completed
First Posted : February 28, 2018
Last Update Posted : February 28, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Anxiety Anxiety Disorders Depressive Symptoms Depressive Disorder Problem Behavior Oppositional Defiant Disorder Conduct Disorder Behavior Disorders | Behavioral: Mind My Mind Behavioral: TAU (Treatment as Usual) | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 150 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | No sample size calculation was performed for this parallel, two-arm feasibility RCT. Because the study population was heterogeneous and included children with a broad spectrum of emotional and behavioral mental health problems, 100-120 children were needed in the new experimental MMM arm to answer the research questions related to implementation and acceptability of the MMM manual. Therefore the goal was to include 150 children to be randomly allocated (3:1) to MMM versus TAU. The central, computerized randomization was performed by DEFACTUM using concealed computer-generated allocation sequences with variable block size, and stratification by region (Zealand or Central Denmark), and by age (6-10 years or 11-16 years). |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | A Randomized Feasibility Trial of a New Transdiagnostic Cognitive and Behavioral Intervention Versus Treatment as Usual in School-aged Children With Emotional and Behavioral Disturbances |
| Actual Study Start Date : | December 8, 2015 |
| Actual Primary Completion Date : | April 2, 2017 |
| Actual Study Completion Date : | April 2, 2017 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: MMM (Mind My Mind training)
Mind My Mind training
|
Behavioral: Mind My Mind
An individual, modular and flexible cognitive and behavioural therapy |
|
Active Comparator: TAU (Treatment as Usual)
Treatment as Usual
|
Behavioral: TAU (Treatment as Usual)
The children were offered anonymous counselling, supportive talk therapy, pedagogical advice, network meetings, and/or individual support in the school setting. A few were offered group-based CBT-programs for selected problems, but the access to manualized treatment was generally very restricted. |
- The flow of participants through the visitation. [ Time Frame: At baseline (week 0). ]
The number of children/parents who accepted the invitation to sign up for visitation to the study The number successfully screened and assessed for eligibility. The number estimated to be eligible. The proportion of eligible children for whom the parents gave informed consent to let the child participate in the research study.
The number excluded in total, and calculated for each inclusion and exclusion criteria.
- The family and social background characteristics. [ Time Frame: At baseline (week 0). ]One of the parents served as an informant. The questionnaire was developed for the Mind My Mind and asked about the family composition including if parents are separated, divorced or living together, how much time the child spend with each parent, early developmental problems, physical and mental health problems and disorders, school problems related to learning, social functioning and absence from school, child's history of having received any pedagogical educational support, medicine, psychological or psychiatric treatments; and parents' education and self-reported mental health problems.
- The Strengths and Difficulties Questionnaire (SDQ). [ Time Frame: At baseline (week 0). ]
SDQ contains 25 items, each scored on a 3-point Likert scale (0, 1, 2), and divided into five sub-scales measuring emotional problems, behavioral problems, hyperactivity, peer problems and pro-social behavior. The extended version included questions about child distress and interference of problems with home-life, friendships, classroom learning and leisure activities, summed up the distress and the interference of problems in the impact score (range 0-10).
For screening purposes, high-risk and low-risk groups were defined by cut-offs for the top 10th percentile of the Danish population. Informants: The SDQ was answered by the child (only age 11 -16 years) and the parent. For those children included in the research trial, the school teacher was requested to answer the SDQ.
- The retention of children in the MMM arm. [ Time Frame: At end of treatment (week 14). ]The proportion continuing training until the agreed and planned ending (minimum 9 sessions) among the total number of children being allocated to MMM training.
- The proportion of children in the MMM arm who were referred to more specialized services during the study period. [ Time Frame: At end of treatment (week 14) ]The number referred to child and adolescent psychiatry or other specialized services according to the mandatory records made by the psychologist at end of the each MMM training.
- The satisfaction with MMM sessions among children and parents in the MMM arm. [ Time Frame: Within one week after each MMM session. ]
The questionnaire contains six questions: 1) I liked the last meeting, 2) I learned something new at the last meeting, 3) All in all, I understood the tasks, 4) I can use what I learned at the last meeting, 5) I felt that the trainer understood me, 6) The trainer presented the tasks in a good way for me.
The questionnaire was scored after each MMM session by the child or by the parent, depending on who was the primary recipient in the given session (as recorded by the therapist). Each question was scored on 5-point likert-scale, score 1 = "very unsatisfied" and 5 = "very satisfied".
- The dosing and sequencing of the MMM modules. [ Time Frame: Within one day after each MMM session. ]The trainer made a record of each training session including information on the current principal problem domain (anxiety, depressive symptoms, behavioural problems), the selected path, modules and worksheets used in the session, the participant (child, parents) the primary recipient, and, if it was the last session, how the training ended (ending as planned, drop out, referral to support/treatment outside the manual).
- The authorized Danish version of the Achenbach System of Empirically Based Assessment (ASEBA), Child Behaviour Checklist (CBCL). [ Time Frame: At baseline (week 0) ]The Child Behaviour Checklist for 6-16-year-olds was answered by the parent. The part with 112 problem items was used. These are statements answered on a Likert scale: zero equals "not true", one equals "partly true or sometimes", two equals "very true or frequently". CBCL derives total problem score, and subscale scores for externalizing and internalizing problems.
- The authorized Danish version of the Achenbach System of Empirically Based Assessment (ASEBA), the Youth Self-Report (YSR). [ Time Frame: At baseline (week 0) ]The YSR was answered by the child (age 11-16- years). The part with 112 problem items was used. These are statements answered on a Likert scale: zero equals "not true", one equals "partly true or sometimes", two equals "very true or frequently". YSR derives total problem score, and subscale scores for externalizing and internalizing problems.
- Spence Children's Anxiety Scale (SCAS) [ Time Frame: Baseline (week 0), end of treatment (week 14), and follow-up (week 22). ]The SCAS comprises parent- and youth-reported questionnaires with 38 and 44 items, respectively. Each is rated on a four-point scale (0-1-2-3). The self-reported version is longer because it includes six positive filler items. The SCAS consists of six subscales reflecting symptoms specifically related to social phobia (SoP; six items), panic disorder and agoraphobia (Panic; nine items), generalized anxiety disorder (GAD; six items), obsessive-compulsive disorder (OCD; six items), separation anxiety disorder (SAD; six items) and fear of physical injury (Fear; five items). Each subscale is scored separately and added together for a total score reflecting overall anxiety symptoms. A validation of the Danish version of the SCAS in children and adolescents aged 7-17 years found good psychometric properties.
- The Mood and Feelings Questionnaire (MFQ) [ Time Frame: Baseline (week 0), end of treatment (week 14), and follow-up (week 22). ]The MFQ comprises parent- and youth-reported questionnaires with 34 and 33 items, respectively; each rated on a three-point scale (0-1-2). The MFQ have well-established predictive validity for detection of depressive states and suicidality in epidemiological and clinical samples of children and adolescents aged 8-17 years, and the parent-reported MFQ has also demonstrated sensitivity for change with treatment.
- The KIDSCREEN [ Time Frame: Baseline (week 0), end of treatment (week 14), and follow-up (week 22). ]
The KIDSCREEN is a Health-Related Quality of Life (HRQOL) questionnaire for children and adolescents aged from 8 to 18 years.
It comprises parent- and youth-reported questionnaires with 27 items, each rated on a five point scale (1-2-3-4-5).
It contains five dimensions (subscales): Physical Well-Being, Psychological Well-Being, Autonomy & Parents, Peers & Social Support and School Environment.
- Eyberg Child Behaviour Inventory (ECBI) [ Time Frame: Baseline (week 0), end of treatment (week 14), and follow-up (week 22). ]The ECBI is a brief, parent-reported behavioral rating scale of externalizing problems in children of age 2-16 years. It consists of 36 items that assess typical problem behavior reported by parents of children with oppositional and conduct disorders. Each item is rated on a 7-point Intensity Scale that indicates how often the behaviors currently occur (0=Never, 4=sometimes, 7=always); and a Problem scale that identifies whether the child's behavior is problematic or not for the parent (1=yes, 0=no). Hence, the sum of scores on the Intensity Scale measures the overall intensity with which the child displays the behaviors, while the sum of scores on the Problem scale measures the number of problematic behaviors.
- Weiss Functional impairment rating Scale (WFIRS) [ Time Frame: Baseline (week 0), end of treatment (week 14), and follow-up (week 22). ]The Weiss Functional Impairment Rating Scale-Parent Report (WFIRS) was designed to evaluate to what degree a child's behavior or emotional problems impacted various domains of daily functioning. It comprises parent- and youth-reported questionnaires with 50 items, each rated on a four-point scale (0-1-2-3). Although it has only been validated (and found very sensitive for change) in clinical samples of children aged 6-17 years with ADHD, it focuses on the impact of emotional and behavioral problems, and hence shows good face validity as a measurement of daily functioning in a much broader group of children with emotional and behavioral problems. The WFIRS covers six dimensions of functioning (subscales): Family and home life, School and learning, Life skills, Self-Concept, Social activities, and Risk behaviors. Only the parent-reported version was used in the present study.
- Parental Stress Scale (PSS) [ Time Frame: Baseline (week 0), end of treatment (week 14), and follow-up (week 22). ]The PSS comprises a parent-reported questionnaire with 18 items, each rated on a five point scale (0-1-2-3-4). It measures the stress a parent may experience as parent of children and adolescents of age 0-18 years. The PSS is currently being validated in Denmark.
- The Experience of Service Questionnaire (ESQ) [ Time Frame: Baseline (week 0), end of treatment (week 14), and follow-up (week 22). ]The ESQ comprises parent- and youth-reported questionnaires with 7 items, each rated on a three-point scale (0-1-2). The Danish version was adapted from a longer English questionnaire asking young people and their parents how they felt about the psychiatric service they received. The brief Danish version proved useful in a recent study of the Cool Kids program in the community.
- Top-3-problems [ Time Frame: Baseline (week 0), weekly during treatment, end of treatment (week 14), and follow-up (week 22). ]
As part of the visitation, the child and the parent were asked to separately identify three problems (Top-3-problems) causing distress or otherwise impacting on the daily life of the child.
The question to the child: "Try to choose the three issues that are most important for you to do something about, because they make you feel uncomfortable or they prevent you from doing the things, you want to do. Please choose which problem is number 1 (the largest), number 2 (second largest) and number 3. We call them your Top-3-problems." The respondent then enter their own formulation of the three "Top-3-problems" into the web-based questionnaire (thereby personalizing the questionnaire), after which they each score each problem on a 10-point scale (0-1-2….10), where a score of 10 means "worst you can imagine", and 1 means "so little that it does not matter at all." The child and the parent each scored their own set of The child and the parent each scored.
- The Brief Problem Monitor (BPM) [ Time Frame: Baseline (week 0), weekly during treatment, end of treatment (week 14), and follow-up (week 22). ]
This standardized questionnaire, BPM, consists of three subscales (internalizing problems, attention problems, externalizing difficulties), and a total problems scale. The 19 items are derived from the CBCL/YSR. The brief scale is designed to monitor children's responses to interventions over periods of days, weeks, or months, and their level of functioning during the course.
The child and the parent each scored the BPM right after the Top-3-problems.
- The Strengths and Difficulties Questionnaire (SDQ). [ Time Frame: Baseline (week 0), weekly during treatment, end of treatment (week 14), and follow-up (week 22). ]
SDQ contains 25 items, each scored on a 3-point Likert scale (0, 1, 2), and divided into five sub-scales measuring emotional problems, behavioral problems, hyperactivity, peer problems and pro-social behavior. The extended version included questions about child distress and interference of problems with home-life, friendships, classroom learning and leisure activities, summed up the distress and the interference of problems in the impact score (range 0-10).
For screening purposes, high-risk and low-risk groups were defined by cut-offs for the top 10th percentile of the Danish population. Informants: The SDQ was answered by the child (only age 11 -16 years) and the parent. For those children included in the research trial, the school teacher was requested to answer the SDQ.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 6 Years to 16 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Aged 6-16 years and in 0-9th grade (excluding the second semester of the 9th grade).
- Bother genders.
- Child and/or parents report that the child has problems within the domains of anxiety, depressive symptoms and behavioral problems.
- SDQ scores reported by the parent are above the lower cutoff: a total difficulties score of ≥14 and/or emotional problems ≥5; combined with a functional impairment score of ≥1.
- The child and at least one of the two parents understand and speak Danish sufficiently to participate in the treatment.
- Written informed consent from the holders of the parental rights and responsibilities (usually both parents).
Exclusion Criteria:
- Indications based on the available information that the child may have a severe mental disorder like autism spectrum disorder, ADHD, schizophrenia-like psychosis, an eating disorder, or other mental disorder requiring referral to a more intensive assessment or treatment in child and adolescent mental health services (after systematic assessment and according to the usual recommendations and guidelines).
- Indications of intellectual functional impairment, severe learning difficulties or other special needs that would interfere negatively with the MMM training. The judgment is made as a best estimate by the PPR psychologist on the basis of the available information. A formal intelligence test is not required.
- The child has a clinically significant abuse of alcohol or psychoactive drugs
- Parents did not answer the SDQ and CBCL during visitation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03448809
| Principal Investigator: | Pia Jeppesen, Ph.D. | Child and Adolescent Mental Health Centre, Mental Health Services of the Capital Region of Denmark |
| Responsible Party: | Pia Jeppesen, Ph.D., Senior Researcher and Specialist in Child and Adolescent Psychiatry, and Associate Professor, Institute for Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark, Mental Health Services in the Capital Region, Denmark |
| ClinicalTrials.gov Identifier: | NCT03448809 |
| Other Study ID Numbers: |
MMMpilotrct |
| First Posted: | February 28, 2018 Key Record Dates |
| Last Update Posted: | February 28, 2018 |
| Last Verified: | February 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Cognitive and Behavioral Therapies Children and Adolescents Community Health Care Early Intervention Feasibility Study |
|
Disease Anxiety Disorders Depressive Disorder Depression Mental Disorders Conduct Disorder |
Attention Deficit and Disruptive Behavior Disorders Problem Behavior Pathologic Processes Mood Disorders Behavioral Symptoms Neurodevelopmental Disorders |

